Life Science Investing Dover, Delaware -- Expert Systems Inc., a leading life sciences accelerator, Supports Traws Pharma Phase 2 Clinical Studies of Ratutrelvir -- a Novel Ritonavir-Free Antiviral for COVID-19. 22 October
Life Science Investing Traws Pharma Doses First Patient with Ratutrelvir in Phase 2 COVID Studies, Expects Results by Year-End 2025 14 October
Life Science Investing Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives 06 October
